SEC Form 4 · accession 0001127602-16-038681
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alane P Barnes
Officer — VP, General Counsel & Corp Sec
Period of report
Jan 29, 2016
Accepted (ET)
Feb 1, 2016 · 2:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2016 | M | 19,368 | $1.42 | A | 85,057 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Emp. Stock Option (Right to Buy) | $1.42 | Jan 29, 2016 | M | 19,368 | D | Jan 1, 2014 | Jan 1, 2023 | Common Stock | 19,368 | 20,632 | D |